Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation

Transplantation

Volumn 83, Issue 7, 2007, Pages 954-963

  Xu, Hong ^a   Chilton, Paula M ^a   Huang, Yiming ^a   Schanie, Carrie L ^a   Yan, Jun ^a   Ildstad, Suzanne T ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Chimerism; Clonal deletion; Humoral immunity; T cells; Tolerance

Indexed keywords

ALLOANTIGEN; CYCLOPHOSPHAMIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY H57 597; MONOCLONAL ANTIBODY UC7 13D5; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADD ON THERAPY; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHIMERA; CONTROLLED STUDY; DENDRITIC CELL; ENGRAFTMENT; GRAFT RECIPIENT; GRAFT REJECTION; HUMORAL IMMUNITY; IMMUNOCOMPETENCE; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; NONMYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; SENSITIZATION; SKIN TRANSPLANTATION; SPLEEN CELL; T CELL DEPLETION; T LYMPHOCYTE; WHOLE BODY RADIATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD4; BONE MARROW TRANSPLANTATION; CYCLOPHOSPHAMIDE; FLOW CYTOMETRY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFUSION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; RECEPTORS, ANTIGEN, T-CELL; SKIN TRANSPLANTATION; SPLEEN; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING;

EID: 34247621759     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000258679.18684.b0     Document Type: Article

References (41)

1. Nagano H, Tilney NL. Chronic allograft failure: the clinical problem. Am J Med Sci 1997; 313: 305.
2. Farges O, Saliba F, Farhamant H, et al. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology 1996; 23: 240.
3. Penn I. Malignancy Surgical Clinics of North America 1994; 74: 1247.
4. Platz KP, Mueller AR, Blumhardt G, et al. Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients. Transpl Int 1994; 7: S52-57.
5. Vercauteren SB, Bosmans JL, Elseviers MM, et al. A meta-analysis and morphological review of cyclosporine-induced nephrotoxicity in autoimmune diseases. Kidney Int 1998; 54: 536.
6. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168.
7. Wekerle T, Sayegh MH, Hill J, et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 1998; 187: 2037.
8. Xu H, Chilton PM, Huang Y, et al. Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism. J Immunol 2004; 172: 1463.
9. Xu H, Exner BG, Cramer DE, et al. CD8(+), αβ-TCR(+), and γδ-TCR(+) Cells in the Recipient Hematopoietic Environment Mediate Resistance to Engraftment of Allogeneic Donor Bone Marrow. J Immunol 2002; 168: 1636.
10. Pang M, Li S, Salgar S, et al. Donor bone marrow infusion reduces the infiltration of recipient-derived CD4 and dendritic cells in lung allograft. J Surg Res 2006; 130: 176.
11. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199.
12. Feng G, Wood K. Regulatory T cells-an emerging role in transplantation. Yonsei Med J 2004; 45: 968.
13. Cassis L, Aiello S, Noris M. Natural versus adaptive regulatory T cells. Contrib Nephrol 2005; 146: 121.
14. Cobbold S, Waldmann H. Infectious tolerance. Curr Opin Immunol 1998; 10: 518.
15. Abe R, Kanagawa O, Sheard MA, et al. Characterization of a new minor lymphocyte stimulatory system. I. Cluster of self antigens recognized by "I-E reactive" V beta s, V beta 5, V beta 11, and V beta 12 T cell receptors for antigen. J Immunol 1991; 147: 739.
16. Beutner U, Frankel WN, Cote MS, et al. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. PNAS USA 1992; 89: 5432.
17. Tomonari K, Fairchild S. The genetic basis of negative selection of Tcrb-V11+ T cells. Immunogenetics 1991; 33: 157.
18. Bill J, Kanagawa O, Woodland DL, Palmer E. The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells. J Exp Med 1989; 169: 1405.
19. Colson YL, Li H, Boggs SS, et al. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. J Immunol 1996; 157: 2820.
20. Li H, Kaufman CL, Boggs SS, et al. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in non-obese diabetic (NOD) mice. J Immunol 1996; 156: 380.
21. Baron F, Baker JE, Storb R, et al. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 2004; 104: 2254.
22. Huang Y, Rezzoug F, Chilton PM, et al. Matching at the MHC Class I K locus is essential for long-term engraftment of purified hematopoietic stem cells: a role for host NK cells in regulating HSC engraftment. Blood 2004; 104: 873.
23. Fudaba Y, Spitzer TR, Shaffer J, et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant 2006; 6: 2121.
24. Khan A, Tomita Y, Sykes M. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation 1996; 62: 380.
25. Sykes M, Szot GL, Swenson KA, Pearson DA. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nature Med 1997; 3: 783.
26. Kawabe Y, Ochi A. Programmed cell death and extrathymic reduction of Vbeta8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 1991; 349: 245.
27. Chen Y, Inobe J, Marks R, et al. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995; 376: 177.
28. Qin S, Cobbold S, Benjamin R, Waldmann H. Induction of classical transplantation tolerance in the adult. J Exp Med 1989; 169: 779.
29. Mayumi H, Himeno K, Tanaka K, et al. Drug-induced tolerance to allografts in mice. IX. Establishment of complete chimerism by allogeneic spleen cell transplantation from donors made tolerant to H-2-identical recipients. Transplantation 1986; 42: 417.
30. Qin S, Cobbold SP, Pope H, et al. "Infectious" transplantation tolerance. Science 1993; 259: 974.
31. Davies JD, Leong LY, Mellor A, et al. T cell suppression in transplantation tolerance through linked recognition. J Immunol 1996; 156: 3602.
32. Sanchez-Fueyo A, Weber M, Domenig C, et al. Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol 2002; 168: 2274.
33. Li XC, Wells AD, Strom TB, Turka LA. The role of T cell apoptosis in transplantation tolerance. Curr Opin Immunol 2000; 12: 522.
34. Edinger M, Hoffmann P, Ermann J, et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versushost disease after bone marrow transplantation. Nat Med 2003; 9: 1144.
35. Graca L, Le MA, Lin CY, et al. Donor-specific transplantation tolerance: the paradoxical behavior of CD4+CD25+T cells. Proc Natl Acad Sci U S A 2004; 101: 10122.
36. Jarvinen LZ, Blazar BR, Adeyi OA, et al. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance. Transplantation 2003; 76: 1375.
37. Sawitzki B, Kingsley CI, Oliveira V, et al. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 2005; 201: 1925.
38. deBaey A, Mende I, Baretton G, et al. A subset of human dendritic cells in the T cell area of mucosa-associated lymphoid tissue with a high potential to produce TNF-alpha. J Immunol 2003; 170: 5089.
39. Makarenkova V, Chakrabarti AK, Liberatore JA, et al. Dendritic cells and natural killer cells interact via multiple TNF family molecules. J Leukoc Biol 2005; 77: 408.
40. Honey K, Bemelman F, Cobbold SP, Waldmann H. High dose bone marrow transplantation induces deletion of antigen-specific T cells in a Fas-independent manner. Transplantation 2000; 69: 1676.
41. George JF, Sweeney SD, Kirklin JK, et al. An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow. Nature Med 1998; 4: 333.